Report cards › Food › Maisie Jane's California Sunshine Products

MAISIE JANE'S

Owned by Maisie Jane's California Sunshine Products · 44 products in USDA FoodData Central · as of Oct 28, 2026 · Report an error · Change log

CSWH grade A (87)

Method v1.0 (how we grade), based on the records below; exact score 87.4545.

Grade by indicator
IndicatorGradeWhat we found
Recalls (40%)B (80)1 Class II (4 points) · 1 event For current recalls see FDA and USDA.
Ingredients (40%)A (89)Tier A: 1 of 44 products (FD&C Red No. 3) · A (89) (25%)
Tier B: 3 of 44 products (FD&C Red No. 40, FD&C Blue No. 1, FD&C Yellow No. 5, FD&C Yellow No. 6, Titanium dioxide, FD&C Blue No. 2) · A (89) (15%) · products
FDA warning letters (20%)A (100)None found to the owner Oct 28, 2021 to Oct 28, 2026.

Shown, not graded: recall reasons (1 other reasons) · IARC notes (0 products) · FDA dye pledge: none on FDA's tracker.

Recalls, Oct 28, 2021 to Oct 28, 2026

  1. Class II, Oct 2, 2023 · Other reasons · FDA event 93165

    • Maisie Jane's Smooth almond butter, 12 oz glass jar, 6 units per case, shelf stable

      Reason (FDA's words)
      High levels of aflatoxin
      Code information
      Lot Code 30122, Best by used by 10/24
      Recalling firm
      Maisie Jane's California Sunshine Products Inc.
      Dates
      Recall started Oct 2, 2023; classified Oct 12, 2023
      Status
      Terminated (status reported by FDA at classification)
      How we matched it
      matched by recalling firm (name) and brand name

      FDA record F-0012-2024: openFDA · Report an error

Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.

Ingredients on our watch list

Products (3)

Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".

FDA warning letters to Maisie Jane's California Sunshine Products, Oct 28, 2021 to Oct 28, 2026

None found from FDA food offices.

FDA notes that later events may have changed the regulatory status of what a letter discusses.